Atrial Fibrillation

This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower  ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion

Xarelto, rivaroxaban, PMSS study, ACC 2016, NVAF, atrial fibrillation, stroke
News | Antiplatelet and Anticoagulation Therapies | April 08, 2016
April 8, 2016 — New data from an ongoing post-marketing study confirm the safety profile of Xarelto (rivaroxaban) was...
Kardia Band, Alivecor

The Alivecor Kardia Band for the Apple Watch enables anyone to perform a medical-grade ECG anywhere.

Technology | Wearables | March 28, 2016
AliveCor, Inc., the leader in FDA-cleared electrocardiogram (ECG) technology for mobile devices, announced today the...
atrial fibrillation patients, high stroke risk, not prescribed medication, JAMA Cardiology study
News | Pharmaceuticals | March 17, 2016
March 17, 2016 — Nearly half of all atrial fibrillation (AF) patients at the highest risk for stroke are not being...
aMAZE Trial enrollment, The Valley Hospital NJ, atrial fibrillation
News | Left Atrial Appendage (LAA) Occluders | March 16, 2016
March 16, 2016 — The Valley Hospital in Ridgewood, N.J., is one of 15 U.S. sites currently enrolling patients in a...
Biotronik, BioMonitor 2, AF remote monitoring, atrial fibrillation, U.K. and Ireland
News | Remote Monitoring | March 14, 2016
March 14, 2016 — Biotronik announced that its BioMonitor 2 heart monitor is now available for patients in the United...
Technology | Ablation Systems | March 11, 2016
March 11, 2016 — Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for the Blazer Open-...
AtriCure, AtriClip, ATLAS study, first patient enrolled, POAF, post-operative atrial fibrillation
News | Structural Heart | February 18, 2016
February 18, 2016 — AtriCure Inc. announced that the first patient was enrolled and treated at PinnacleHealth Hospitals...
Watchman, LAA closure device, cost effectiveness, VIvek Reddy, stroke reduction, study
News | Left Atrial Appendage (LAA) Occluders | January 06, 2016
January 6, 2016 — A new study determined that the Watchman left atrial appendage closure device is more cost-effective...

Photo courtesy of Vital Images

News | ACC | December 22, 2015
December 22, 2015 — In 2015, results from the ITALIC and CvLPRIT trials, along with studies examining lifestyle factors...
ROCKET AF, executive committee, secondary analysis, rivaroxaban, FDA recall
News | Antiplatelet and Anticoagulation Therapies | December 17, 2015
December 17, 2015 — The ROCKET AF Clinical Trial Executive Committee announced its secondary analysis of the phase III...
Biotronik, CLS, B3 clinical trial, atrial fibrillation, AF patients, stroke risk
News | EP Lab | December 08, 2015
December 8, 2015 — Biotronik announced the first patient enrollments to the B3 clinical trial. The study will evaluate...
coherex Wave Crest LAA Occluder

Coherex WaveCrest Left Atrial Appendage (LAA) Occlusion System.

News | November 24, 2015
November 24, 2015 — Biosense Webster announced it has acquired Coherex Medical Inc., a privately held medical device...
Boston Scientific, Watchman FLX, LAA closure device, CE mark, first European implants
News | Left Atrial Appendage (LAA) Occluders | November 20, 2015
November 20, 2015 — Boston Scientific announced the first implants of the Watchman FLX left atrial appendage closure (...
Pradaxa, warfarin, safety and effectiveness, NVAF, non-valvular atrial fibrillation, clinical trial, AHA Scientific Sessions
News | Antiplatelet and Anticoagulation Therapies | November 11, 2015
November 11, 2015 — Brigham and Women’s Hospital in Boston and Boehringer Ingelheim announced the results of a new...
StopAfib.org, atrial fibrillation, AF-related stroke, patient engagement materials

Infographic courtesy of StopAfib.org
 

News | Stroke | November 03, 2015
November 3, 2015 — In recognition of World Stroke Day, the patient-focused organization StopAfib.org launched a diverse...